Clinical Trial Update: Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating botulinum toxin injections to prevent atrial fibrillation in cardiac surgery patients; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Surgery-associated Atrial Fibrillation

Drugs mentioned

• Botulinum toxin injections (botulinum toxin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cardiac Surgery | Phase 3 | Status: ACTIVE_NOT_RECRUITING